3rd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit

The 3rd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit explores the use of Real World Evidence, health economics, pricing, and market access strategies to inform drug development and healthcare decisions in the UK.

Key Topics

• Real World Data (RWD)
• Real World Evidence (RWE)
• Pricing & Market Access
• Health Economics and Outcomes Research (HEOR)
• Value-Based Healthcare
• HTA & Reimbursement Pathways
• Patient-Centric Data
• Evidence Generation
• Regulatory Evidence Requirements
• Comparative Effectiveness Research
• Data Quality & Integration
• Digital Health & AI in Evidence

Who should Attend

• Biotech Leaders
• Pharmaceutical Professionals
• HEOR Specialists
• Market Access Managers
• Medical Affairs Teams
• RWE Scientists
• Regulatory Affairs Experts
• Clinical Research Professionals
• HTA Stakeholders
• Pricing & Reimbursement Teams
• Patient Engagement Leads
• Data Science & Analytics Professionals
• Evidence Generation Teams
• Healthcare Consultants
• Policy & Decision Makers